A simple clip could increase quality of life for thousands of patients with a common heart problem

December 15, 2011

The interventional cardiology team at the Montreal Heart Institute (MHI) recently conducted the first clinical procedure in Canada using the MitraClip system, which is designed to treat patients suffering from mitral valve failure, a very common heart defect that affects an estimated 1 out 5 people to various extents starting at the age of 55. The MHI has implemented a treatment program for this condition and so far is the centre that has performed the most procedures in Canada with the MitraClip system.

This innovative and minimally is an alternative to heart surgery. Until now, mitral valve failure has been treated with medication or open-heart surgery depending on the degree of severity. The MitraClip system was designed by Abbott Vascular for inoperable or very high-risk and can provide lasting treatment for acute mitral regurgitation. The risk of complications is low compared to , and patients are discharged from the hospital within 48 hours of the procedure.

The first procedure was performed by a multidisciplinary team made up of cardiologists Anita Asgar, Anique Ducharme, Raoul Bonan and Arsène Basmadjian along with anesthesiologists Jennifer Cogan and Baqir Qizilbash. "All initial cases went well, and we believe that the long-term outcomes for this procedure will be favourable," stated Dr. Anita Asgar, interventional cardiologist and Assistant Professor in the Faculty of Medicine at Université de Montréal. "Since it allows patients to regain autonomy and quality of life, we believe that this treatment will reduce the number of hospital admissions and visits to emergency due to symptom reoccurrence."

The procedure consists of using a catheter to guide the MitraClip, a simple clip device, through the femoral vein to the left atrium of the heart and then pushing it into the ventricle. The clip is then positioned so that it holds the anterior and posterior flaps of the together. This creates a double orifice opening that allows blood to flow on both sides of the clip, which mechanically restricts regurgitation.

Explore further: MitraClip Therapy demonstrates benefits for heart failure patients

Related Stories

MitraClip Therapy demonstrates benefits for heart failure patients

August 29, 2011
Results of an observational study presented at the European Society of Cardiology (ESC) meeting today in Paris demonstrate that the percutaneous catheter-based MitraClip treatment improves symptoms and promotes reverse left ...

Atrial fibrillation may be root cause of some severe mitral regurgitation cases

September 22, 2011
Mitral regurgitation is a common heart valve disorder, where blood flows backwards through the mitral valve when the heart contracts and reduces the amount of blood that is pumped out to the body. It is a serious condition ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.